These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1068542)

  • 1. Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol).
    Tomov C; Avramova D; Ghenova V; Gigova D; Georgiev Z
    Ther Hung; 1976; 24(2):56-9. PubMed ID: 1068542
    [No Abstract]   [Full Text] [Related]  

  • 2. [10-years experience with myelobromol treatment of myelofibrosis].
    Klimova NF
    Haematologia (Budap); 1977; 11(1-2):57-72. PubMed ID: 615089
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic myeloid leukaemia with myelobromol.
    Petrányi G; Bobory J
    Ther Hung; 1966; 14(4):136-40. PubMed ID: 5228102
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative essay of drugs in the treatment of chronic myeloid leukaemia.
    Petrany G
    Haematologica; 1972 Apr; 57(11):717-21. PubMed ID: 4200306
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dibromomannitol in the treatment of chronic myelogenous leukemia: report of 22 cases].
    Zhu XQ; Qian JW; Dai LY
    Zhonghua Nei Ke Za Zhi; 1988 Mar; 27(3):157-8, 197. PubMed ID: 3146485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic myeloid leukemia with Myelobromol].
    Petrányi G; Bobory J
    Orv Hetil; 1967 Apr; 108(15):689-92. PubMed ID: 5233089
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplantation in accelerated chronic granulocytic leukaemia using dibromomannitol-preconditioning instead of total-body irradiation.
    Kelemen E; Jánossa M; Triska E; Szalay F; Váradi A; Magyar T; Sellyei M
    Leuk Res; 1985; 9(8):1009-15. PubMed ID: 3930887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results in the treatment of chronic myeloid leukaemia.
    Nasr AL; Aboul-Enein M; Tawfik HN
    Haematologica; 1972 Apr; 57(11):794-802. PubMed ID: 4200314
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
    Silver RT; Mick R; Cooper R; Ellison RR; Levy R; Brunner K; Schwartz JM; Holland JF
    Cancer; 1987 Oct; 60(7):1442-8. PubMed ID: 3113712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of polycythemia vera with dibromomannitol (author's transl)].
    Yonemitsu H; Kanazawa S; Kondo H; Yamaguchi K; Okuda K; Shigeta H
    Rinsho Ketsueki; 1980 May; 21(5):587-91. PubMed ID: 6774132
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
    Maurice PA
    Rev Med Suisse Romande; 1970 Jun; 90(6):521-32. PubMed ID: 5293581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
    Urasiński I; Mysik M
    Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myelobromol treatment of patients with chronic myeloleukosis].
    Cherntsova TA; Klimova NF; Susoeva VM
    Klin Med (Mosk); 1967 Jul; 45(7):96-104. PubMed ID: 5250315
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical application of myelobromol in chronic myeloses.
    Cerný V; Ujházy V; Sándor L; Winkler A; Uhrínová M; Petrek C; Halko J
    Neoplasma; 1966; 13(2):177-80. PubMed ID: 5222995
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia].
    Kelemen E; Dénes R; Barta A; Masszi T; Reményi P; Pálóczi K; Bátai A; Torbágyo E; Sipos A; Lengyel L; Jakab K; Gyódi E; Réti M; Földi J; Páldi-Haris P; Manuel A; Fekete S; Török J; Hoffer I; Jakab J; Váradi G; Petrányi G
    Orv Hetil; 1998 Aug; 139(34):2003-1; discussion 2011-2. PubMed ID: 9745304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in the treatment of chronic myeloid leukemia].
    Herrmann R
    Med Klin; 1980 Aug; 75(18):645-9. PubMed ID: 6106883
    [No Abstract]   [Full Text] [Related]  

  • 17. [Short-term massive myelobromol therapy in polycythemia vera: a 12-years' experience. Model for a clinical trial of cytostatic drugs].
    Kelemen E
    Orv Hetil; 1983 Jan; 124(1):3-13. PubMed ID: 6402751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic myelocytic leukemia. Is the insufficient treatment at the terminal stage a reason for changing therapeutical tactics of the chronic phase?].
    Cerný V; Koza I; Hal'ko J; Bohunický L; Krizan Z; Poliaková L; Petrek C; Korec S
    Vnitr Lek; 1974 Sep; 20(8):741-5. PubMed ID: 4527291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results and perspectives of therapy of chronic myelosis].
    Jaworkowsky L; Blumenthal R; Udris O; Sihle M; Terebkowa S
    Z Gesamte Inn Med; 1983 Jun; 38(11):307-9. PubMed ID: 6351448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
    Horváth IP; Somfai-Relle S; Hegedüs L; Jarman M
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):573-7. PubMed ID: 6811281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.